SlideShare une entreprise Scribd logo
1  sur  49
Télécharger pour lire hors ligne
Acute Respiratory Distress
Syndrome
Dr. Rikin Hasnani
Post Graduate
Dept Of Pulmonary Medicine
SVS Medical College
Mahabubnagar
Telangana State
• Introduction
• Pathophysiology
• Clinical features
• Management
Introduction And Definition
• In 1967, Ashbaugh et al. described a syndrome characterized by the
acute onset of dyspnea, severe hypoxemia, diffuse lung infiltrates,
and decreased respiratory system compliance in the absence of
evidence for congestive heart failure (CHF).
• In 1988, Murray and others introduced the Lung Injury Score (LIS), an
assessment tool for ARDS.
• The LIS incorporates four parameters that are graded on a scale of 0
to 4: (1) ratio of PaO2 to FIO2(PaO2/FIO2); (2) total respiratory
compliance;(3) level of PEEP; and (4) extent of radiographic infiltrates.
• In 1994 American European Consensus Conference (AECC) defined
ARDS and ALI.
Consensus Definition of ARDS
• The AECC defines ARDS as the acute onset of illness with bilateral
chest radiographic infiltrates consistent with pulmonary edema, poor
systemic oxygenation, and absence of evidence for left atrial
hypertension.
• The syndrome was referred to as ALI when the ratio of PaO2 to FIO2
(PaO2/FIO2); was ≤300, and ARDS when the ratio was ≤200.
• Limitations of this Definition.
Berlin Definition - 2012
While the Berlin definition leaves the AECC definition
of ARDS largely unchanged, the new definition
addresses several specific ambiguities of the prior
diagnostic criteria.
Epidemiology
• Incidence 75 cases per lakh population
• Mortality 26 to 58%
• more people die annually with ARDS than from AIDS, asthma, and
breast cancer combined.
• The most common causes of death among patients with ARDS arise
from the underlying insult or subsequent nosocomial pneumonia and
sepsis.
• Only rarely do patients die from progressive hypoxia and respiratory
failure.
Cause of ARDS
Factors influencing risk of ARDS
• Not all patients with an underlying cause (e.g., sepsis) of ARDS
develop the syndrome.
• Clinical variables found to be associated with an increased risk of
ARDS include chronic alcohol abuse, hypoproteinemia, advanced age,
increased severity, and extent of injury or illness as measured by
injury severity score (ISS) or APACHE score, hypertransfusion of blood
products, and cigarette smoking.
• Diabetes mellitus and prehospitalization antiplatelet therapy appear
to decrease the risk of ARDS
Acute Respiratory Distress Syndrome
Predicting ARDS-Lung injury prediction score (LIPS)
• It is generated by sum of six predisposing factors and 9 risk modifiers.
• six predisposing conditions are shock, aspiration, sepsis, pneumonia,
high-risk surgery, and high-risk trauma
• nine risk modifiers alcohol abuse, obesity, hypoalbuminemia,
chemotherapy, need for oxygen, tachypnea, hypoxia, academia, and
diabetes mellitus
• The negative predictive value for a score <4 was 97%, while the
sensitivity and specificity for ARDS of a score >4 were 69% and 78%,
respectively.
Pathophysiology
• The essential factors that govern fluid exchange in the lungs are
expressed in the Starling equation for the microvascular barrier:
Jv = LpS[(Pc – Pi) – σd(πc – πi)]
The Starling equation predicts the development of two different kinds
of pulmonary edema.
Increased pressure pulmonary edema
Increased permeability pulmonary edema
Acute Respiratory Distress Syndrome
Stages of ARDS
Resolution of ARDS
• Resolution of ARDS requires effective:
• (1) reabsorption of alveolar edema,
• (2) repair of the epithelial and endothelial barriers, and
• (3) removal of inflammatory cells and exudates from the distal
airspaces.
Clinical Presentation
• The development of ARDS usually follows a rapid course, occurring most
often within 12 to 72 hours of the predisposing event.
• Dyspnea usually associated with agitation, anxiety.
• As lung compliance decreases there is increased WOB, small tidal volume
and tachypnea.
• The hallmark of ARDS is hypoxemia that is resistant to oxygen therapy
because of the large right-to left shunt.
• Initially, patients may be able to compensate by hyperventilating, thereby
maintaining an acceptable PaO2 with an acute respiratory alkalosis.
• Typically, patients deteriorate over several hours, requiring endotracheal
intubation and mechanical ventilation.
Differential Diagnosis of Acute Hypoxemic
Respiratory Failure (AHRF)
Approach to clinical Diagnosis
• Chest x ray
Lab investigations
• Tropnin, BNP
• LFT, RFT, hemogram
• Bronchoscopy
• Pancultures
• Invasive hemodynamic monitoring is not recommended
Approach to Treatment
• Treatment of respiratory system abnormalities
• Diagnose and treat the precipitating cause of ARDS, if possible
• Maintain oxygenation, preferably using nontoxic FIO2 (<0.7), PEEP, or mechanical
ventilation
• Prevent ventilator-induced lung injury (VILI) by using a low tidal volume ventilatory
strategy with a limit (≤30 cm H2O) on static end-inspiratory airway pressure
(plateau pressure)
• Keep pH in normal range without compromising goal to prevent VILI (but reverse a
lifethreatening acidosis, even if it prevents meeting goal to prevent VILI)
• Enhance patient–ventilator synchrony and patient comfort by use of sedation,
amnesia, opioid analgesia, and pharmacologic paralysis, if necessary
• Liberate or wean from mechanical ventilation when patient can breathe without
assisted ventilation
• Treatment of nonrespiratory system abnormalities
• Support or treat other organ system dysfunction or failure
• General critical care (preventive and homeostatic measures)
• Adequate early nutritional support
Treating inciting cause of ARDS
Maintaining Adequate oxygenation
• High flow oxygen systems
• Niv
• Mechanical ventilation
Lung protective MV
• In contrast to the typical diffuse-appearing
pattern noted on plain chest radiographs, the
pattern of consolidation, atelectasis, and
normal alveoli is actually heterogeneous.
• The key physiologic implication of these
observations is that a ventilator-delivered
tidal volume is preferentially distributed to
the open alveoli, which represent only a small
fraction of the entire lung, BABY LUNG
Acute Respiratory Distress Syndrome
• The goals of lung-protective ventilation are to avoid injury due to
overexpansion of alveoli during inspiration (so-called “volu-trauma”)
and injury due to repetitive opening and closing of alveoli during
inspiration and expiration (so-called “atelecta-trauma”).
• The term “bio-trauma” encompasses the direct lung injury and the
concomitant release of inflammatory cytokines that produce remote
cell death or organ injury.
Ventilator Strategy in ARDS
1. Ventilator Setup and Adjustment
2. Oxygenation Goal: PaO2 = 55–80 mm Hg or SpO2 = 88–95%
3. Plateau Pressure (Pplat) goal:≤30 cm H2O
4. pH Goal: 7.30–7.45
Ventilator Setup and Adjustment
• 1. Calculate ideal body weight (IBW)a (also known as predicted body
weight [PBW])
• 2. Use Assist/Control mode and set initial TV to 8 mL/kg IBW (if baseline TV
>8 mL/kg)
• 3. Reduce TV by 1 mL/kg at intervals ≤2 h until TV = 6 mL/kg IBW
• 4. Set initial rate to approximate baseline minute volume (but not >35
bpm)
• 5. Adjust TV and RR to achieve pH and plateau pressure (Pplat) goals below.
• 6. Set inspiratory flow rate above patient demand (usually >80 L/min);
adjust flow rate to achieve goal of I:E ratio of 1:1.0–1.3
Oxygenation Goal:
• Goal is PaO2 = 55–80 mm Hg or SpO2 = 88–95%
• 1. Use these incremental FIO2-PEEP combinations to achieve
oxygenation goal
Plateau Pressure (Pplat) goal:≤30 cm H2O
• 1. Check Pplat (use 0.5-s inspiratory pause), SpO2, total RR, TV, and
ABG (if available) at least every 4 h and after each change in PEEP or
TV.
• 2. If Pplat >30 cm H2O, decrease TV by 1 mL/kg steps (minimum 4
mL/kg IBW)
• 3. If Pplat <25 cm H2O and TV <6 mL/kg, increase TV by 1 mL/kg until
Pplat >25 cm H2O or TV = 6 mL/kg.
• 4. If Pplat <20 cm H2O and breath stacking occurs, one may increase
TV in 1 mL/kg increments (to a maximum of 8 mL/kg)
pH Goal: 7.30–7.45
• Acidosis management: pH <7.30
• 1. If pH = 7.15–7.30, increase RR until pH >7.30 or PaCO2 <25 mm Hg
(maximum RR = 35); if RR = 35 and PaCO2 <25 mm Hg, may give
NaHCO3
• 2. If pH <7.15 and NaHCO3 considered or infused, TV may be
increased in 1 mL/kg steps until pH>7.15 (Pplat goal may be
exceeded)
Rescue” or “Salvage” Interventions Used in Patients with ARDS and
Severe Hypoxemia Resistant to Conventional Mechanical Ventilation and
PEEP
• Corticosteroids
• Extracorporeal CO2 removal (ECCO2R)
• Extracorporeal membrane oxygenation (ECMO)
• High-frequency oscillatory ventilation (HFOV)
• Inhaled nitric oxide (NO) or inhaled prostacyclin (epoprostenol/iloprost)
• Pressure-controlled inverse ratio ventilation (PC-IRV)
• Prone positioning
• Recruitment maneuvers
• Tracheal gas insufflation (TGI)
Corticosteroid
• The study revealed no differences in 60- or 180-day mortality rates.
• Although parameters of respiratory function, including PaO2/FIO2; plateau
pressure; respiratory system compliance; and time to, and rate of,
liberation from mechanical ventilation improved after corticosteroid
administration; the corticosteroid treated group included more patients
who returned to assisted ventilation.
• Furthermore, no statistically significant differences between treated and
untreated groups in ICU or hospital days by 180 days were observed.
• In addition, more adverse events related to weakness occurred in the
treated group than in those receiving placebo.
• Finally, patients treated with corticosteroids after 14 days of persistent
ARDS had a significantly increased mortality.
• Hence, the results of this study do not support the routine use of steroids
for late phase ARDS in general, and they argue against their use if ARDS has
been present for 14 days or longer.
Extracorporeal Life Support
• Extracorporeal Life Support (ECLS) is a therapy that utilizes an external
artificial membrane and a mechanical pump to provide gas exchange
and systemic perfusion in patients with failure of lung and/or heart
function.
• The use of extracorporeal gas exchange, is based on the hypothesis
that more patients will survive if the lung is allowed to recover from
its injury by “resting” using extracorporeal gas exchange temporarily.
• Extracorporeal membrane oxygenation (ECMO) and extracorporeal
CO2 removal (ECCO2R) are types of ECLS.
Death or severe disability, the study’s primary outcome, occurred in 53% of the
conventional arm versus 37% of those referred to the ECMO center.
Among those referred to the ECMO center, 76% received ECMO.
While the study demonstrated a statistically significant finding, the study design
makes it impossible to distinguish the effects of the ECMO therapy from those
of a specialized referral center.
High-frequency oscillatory ventilation (HFOV)
• High-frequency oscillatory ventilation (HFOV) is a mode of ventilation
in which patients are supported with rapid pressure oscillations that
generate very small tidal volumes.
• Theoretically, HFOV may be regarded as the ultimate low-tidal volume
ventilator.
• There is no significant mortality benefit over usual icu care. So not
recommended
Inhaled NO
• Given via inhalation, NO selectively vasodilates pulmonary capillaries
and arterioles that serve ventilated alveoli, diverting blood flow to
these alveoli and away from areas of shunt.
• Lowering of the pulmonary vascular resistance, accompanied by
lowering of the pulmonary artery pressure, appears maximal at very
low concentrations (0.1 ppm) in patients with ARDS.
• Inhaled NO has been studied in several controlled clinical trials in
patients with ARDS.
• While demonstrating improvements in oxygenation in some patients,
inhaled NO did not improve survival in any of the trials.
Tracheal Gas Insufflation
• Tracheal gas insufflation (TGI) consists of delivering fresh gas through
a modified endotracheal tube at a point just above the carina.
• The additional gas flow (i.e., flow provided in addition to the standard
tidal volumes delivered by the ventilator) tends to remove CO2-rich
gas from the trachea and smaller airways.
• Disadvantage with TGI - tracheal erosion, oxygen toxicity related to
an increased FIO2, and hemodynamic compromise or barotrauma
due to TGI-induced auto-PEEP and a larger tidal volume than the
ventilator is set to deliver
• its routine use is not recommended.
PCV -IRV
• PCV can limit maximal peak airway pressure as well as end-inspiratory
pressure and, hence, is favored by some clinicians.
• However, the end-inspiratory pressure in PCV can be underestimated
• TV delivered at set pressure is compliance dependent. Tv will increase
as ARDS improves.
• Inverse ratio ventilation (IRV) with PCV is based upon an inspiratory
time (I) greater than expiratory time (E), that is, I:E >1 .
• Lengthening the inspiratory time increases mean airway pressure
because more of the respiratory cycle is spent in inspiration, which
may translate into improvements in oxygenation.
Prone Ventilation
• About two-thirds of patients with ARDS improve their oxygenation
after being placed in a prone position.
• Mechanisms that improves oxygenation
• (1) increased functional residual capacity;
• (2) change in regional diaphragmatic motion;
• (3) perfusion redistribution; and
• (4) improved clearance of secretions.
Acute Respiratory Distress Syndrome
Problems with prone ventilation
• Patients managed in the prone position need special attention to
prevent pressure necrosis of the nose, face, and ears.
• Extra care is also needed to ensure security and patency of the
endotracheal tube.
• Pressure on the eye may result in retinal ischemia, especially in
hypotensive patients.
• There are incidence of cardiac arrhythmias or hemodynamic
instability when turned prone.
Acute Respiratory Distress Syndrome
Recruitment maneuver
• Lung recruitment maneuvers are defined as the application of CPAP aimed
at “recruiting” or opening totally or partially collapsed alveoli.
• The alveoli are then kept inflated during expiration using an appropriately
high level of PEEP.
• Methods of recruitment
1. 40cmH20 for 40-60 seconds
2. 3 consecutive sighs/min with a plateau pressure of 45cmH2O
3. 2 minutes of peak pressure of 50cmH2O and PEEP above upper inflection
point (obese/trauma patients may require >60-70cmH2O)
4. long slow increase in inspiratory pressure up to 40 cmH2O (RAMP)
5. stepped increase in pressure (e.g. Staircase Recruitment Manoeuvre)
Fluid therapy
• FACTT investigators developed a detailed fluid management protocol
that, except for patients in shock (mean arterial pressure [MAP] less
than 60 mm Hg or on vasopressors for hypotension), used four basic
input variables (assessed every 1–4 hours) to determine the fluid
management instructions:
• (1) MAP;
• (2) urine output;
• (3) effectiveness of circulation; and
• (4) intravascular pressure (central venous pressure [CVP] or PAOP
Acute Respiratory Distress Syndrome
Other therapies
• Neuromuscular blocking agent
• Beta agonists
• Macrolide
• Statins
THANK YOU

Contenu connexe

Tendances

Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeDang Thanh Tuan
 
Ards 2018
Ards 2018Ards 2018
Ards 2018imran80
 
Ventilator strategies in ARDS
Ventilator strategies in ARDSVentilator strategies in ARDS
Ventilator strategies in ARDSAwaneesh Katiyar
 
Ards and ventilator management
Ards and ventilator managementArds and ventilator management
Ards and ventilator managementAmr Elsharkawy
 
ACUTE RESPIRATORY DYSTRESS SYNDROME
ACUTE RESPIRATORY  DYSTRESS SYNDROME ACUTE RESPIRATORY  DYSTRESS SYNDROME
ACUTE RESPIRATORY DYSTRESS SYNDROME KamaliKiruba
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndromeMaged Abulmagd
 
Ventilatory strategies in ARDS
Ventilatory strategies in ARDSVentilatory strategies in ARDS
Ventilatory strategies in ARDSisakakinada
 
Updates on Acute respiratory distress syndrome
Updates on Acute respiratory distress syndromeUpdates on Acute respiratory distress syndrome
Updates on Acute respiratory distress syndromeHamdi Turkey
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeNIKHIL DWIVEDI
 
Management of Respiratory Failure
Management of Respiratory FailureManagement of Respiratory Failure
Management of Respiratory Failureyuyuricci
 
Ventilator Induced Lung Injury
Ventilator Induced Lung InjuryVentilator Induced Lung Injury
Ventilator Induced Lung InjuryDr.Mahmoud Abbas
 
Acute respiratory distress syndrome(ARDS)
Acute respiratory distress syndrome(ARDS)Acute respiratory distress syndrome(ARDS)
Acute respiratory distress syndrome(ARDS)Melaku Yetbarek,MD
 

Tendances (20)

Ventilation in ARDS
Ventilation in ARDSVentilation in ARDS
Ventilation in ARDS
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
 
Ards 2018
Ards 2018Ards 2018
Ards 2018
 
Ventilator strategies in ARDS
Ventilator strategies in ARDSVentilator strategies in ARDS
Ventilator strategies in ARDS
 
Ards and ventilator management
Ards and ventilator managementArds and ventilator management
Ards and ventilator management
 
ARDS
ARDSARDS
ARDS
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
Ards
ArdsArds
Ards
 
ACUTE RESPIRATORY DYSTRESS SYNDROME
ACUTE RESPIRATORY  DYSTRESS SYNDROME ACUTE RESPIRATORY  DYSTRESS SYNDROME
ACUTE RESPIRATORY DYSTRESS SYNDROME
 
Ards atef
Ards atefArds atef
Ards atef
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
ARDS
ARDSARDS
ARDS
 
ARDS
ARDSARDS
ARDS
 
hypercarbia
 hypercarbia hypercarbia
hypercarbia
 
Ventilatory strategies in ARDS
Ventilatory strategies in ARDSVentilatory strategies in ARDS
Ventilatory strategies in ARDS
 
Updates on Acute respiratory distress syndrome
Updates on Acute respiratory distress syndromeUpdates on Acute respiratory distress syndrome
Updates on Acute respiratory distress syndrome
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
 
Management of Respiratory Failure
Management of Respiratory FailureManagement of Respiratory Failure
Management of Respiratory Failure
 
Ventilator Induced Lung Injury
Ventilator Induced Lung InjuryVentilator Induced Lung Injury
Ventilator Induced Lung Injury
 
Acute respiratory distress syndrome(ARDS)
Acute respiratory distress syndrome(ARDS)Acute respiratory distress syndrome(ARDS)
Acute respiratory distress syndrome(ARDS)
 

En vedette

Ct diffuse lung disease
Ct diffuse lung diseaseCt diffuse lung disease
Ct diffuse lung diseaseRikin Hasnani
 
Information Education Communication in RNTCP
Information Education Communication in RNTCPInformation Education Communication in RNTCP
Information Education Communication in RNTCPRikin Hasnani
 
Lung in pancreatitis
Lung in pancreatitisLung in pancreatitis
Lung in pancreatitisRikin Hasnani
 
Congenital Disorder of lung
Congenital Disorder of lungCongenital Disorder of lung
Congenital Disorder of lungRikin Hasnani
 
Pulmonary artery Hypertension
Pulmonary artery HypertensionPulmonary artery Hypertension
Pulmonary artery HypertensionRikin Hasnani
 
Lung transplantation
Lung transplantationLung transplantation
Lung transplantationRikin Hasnani
 
Endobronchial ultrasound - EBUS
Endobronchial ultrasound - EBUSEndobronchial ultrasound - EBUS
Endobronchial ultrasound - EBUSRikin Hasnani
 
Eosinophillic pneumonia
Eosinophillic pneumoniaEosinophillic pneumonia
Eosinophillic pneumoniaRikin Hasnani
 
Pulmonary thromboembolism
Pulmonary thromboembolismPulmonary thromboembolism
Pulmonary thromboembolismRikin Hasnani
 
Obstructive sleep Apnea
Obstructive sleep ApneaObstructive sleep Apnea
Obstructive sleep ApneaRikin Hasnani
 
Immunohistochemistry in lung cancer
Immunohistochemistry in lung cancerImmunohistochemistry in lung cancer
Immunohistochemistry in lung cancerRikin Hasnani
 
Chest x ray - basics
Chest x ray - basicsChest x ray - basics
Chest x ray - basicsRikin Hasnani
 
Imaging modalities of diaphragm
Imaging modalities of diaphragmImaging modalities of diaphragm
Imaging modalities of diaphragmArif S
 
Power blog conceptos habilidades
Power blog conceptos habilidadesPower blog conceptos habilidades
Power blog conceptos habilidadeslausarplani
 
The Chest Wall, Pleura, Diaphragm and Intervention 10 Dr. Muhammad Bin Zulfiqar
The Chest Wall, Pleura,Diaphragm and Intervention 10 Dr. Muhammad Bin ZulfiqarThe Chest Wall, Pleura,Diaphragm and Intervention 10 Dr. Muhammad Bin Zulfiqar
The Chest Wall, Pleura, Diaphragm and Intervention 10 Dr. Muhammad Bin ZulfiqarDr. Muhammad Bin Zulfiqar
 

En vedette (17)

Ct diffuse lung disease
Ct diffuse lung diseaseCt diffuse lung disease
Ct diffuse lung disease
 
Information Education Communication in RNTCP
Information Education Communication in RNTCPInformation Education Communication in RNTCP
Information Education Communication in RNTCP
 
Lung in pancreatitis
Lung in pancreatitisLung in pancreatitis
Lung in pancreatitis
 
Mers
MersMers
Mers
 
Congenital Disorder of lung
Congenital Disorder of lungCongenital Disorder of lung
Congenital Disorder of lung
 
Pulmonary artery Hypertension
Pulmonary artery HypertensionPulmonary artery Hypertension
Pulmonary artery Hypertension
 
Lung transplantation
Lung transplantationLung transplantation
Lung transplantation
 
Endobronchial ultrasound - EBUS
Endobronchial ultrasound - EBUSEndobronchial ultrasound - EBUS
Endobronchial ultrasound - EBUS
 
Eosinophillic pneumonia
Eosinophillic pneumoniaEosinophillic pneumonia
Eosinophillic pneumonia
 
Pulmonary thromboembolism
Pulmonary thromboembolismPulmonary thromboembolism
Pulmonary thromboembolism
 
Obstructive sleep Apnea
Obstructive sleep ApneaObstructive sleep Apnea
Obstructive sleep Apnea
 
Immunohistochemistry in lung cancer
Immunohistochemistry in lung cancerImmunohistochemistry in lung cancer
Immunohistochemistry in lung cancer
 
Chest x ray - basics
Chest x ray - basicsChest x ray - basics
Chest x ray - basics
 
Imaging modalities of diaphragm
Imaging modalities of diaphragmImaging modalities of diaphragm
Imaging modalities of diaphragm
 
Power blog conceptos habilidades
Power blog conceptos habilidadesPower blog conceptos habilidades
Power blog conceptos habilidades
 
The Chest Wall, Pleura, Diaphragm and Intervention 10 Dr. Muhammad Bin Zulfiqar
The Chest Wall, Pleura,Diaphragm and Intervention 10 Dr. Muhammad Bin ZulfiqarThe Chest Wall, Pleura,Diaphragm and Intervention 10 Dr. Muhammad Bin Zulfiqar
The Chest Wall, Pleura, Diaphragm and Intervention 10 Dr. Muhammad Bin Zulfiqar
 
Diaphragm
DiaphragmDiaphragm
Diaphragm
 

Similaire à Acute Respiratory Distress Syndrome

Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndromeAsraf Hussain
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndromeAmit Badgal
 
Presentasi text book reading.pptx
Presentasi text book reading.pptxPresentasi text book reading.pptx
Presentasi text book reading.pptxdr. andrea wahyu
 
Presentasi text book reading.pptx
Presentasi text book reading.pptxPresentasi text book reading.pptx
Presentasi text book reading.pptxdr. andrea wahyu
 
Ventilotry managemant of ards
Ventilotry managemant of ardsVentilotry managemant of ards
Ventilotry managemant of ardsDrAvinashKumar6
 
ARDS Acute Respiratory Syndrome
ARDS Acute Respiratory SyndromeARDS Acute Respiratory Syndrome
ARDS Acute Respiratory SyndromeDee Evardone
 
Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0MAGED ABULMAGD
 
Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0MAGED ABULMAGD
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndromeTHANUJA MATHEW
 
Medical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory DiseasesMedical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory DiseasesHadi Munib
 
Acute lung injury
Acute lung injury Acute lung injury
Acute lung injury HI HI
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)rsd8106
 
COPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptxCOPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptxLeelawathyPandian
 
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary DiseaseKoppala RVS Chaitanya
 
G M C F I N A L
G M C  F I N A LG M C  F I N A L
G M C F I N A Lgoolappa
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromePriyaRamalingam6
 
3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptxRaj Kumar
 

Similaire à Acute Respiratory Distress Syndrome (20)

Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
Presentasi text book reading.pptx
Presentasi text book reading.pptxPresentasi text book reading.pptx
Presentasi text book reading.pptx
 
Presentasi text book reading.pptx
Presentasi text book reading.pptxPresentasi text book reading.pptx
Presentasi text book reading.pptx
 
Ventilotry managemant of ards
Ventilotry managemant of ardsVentilotry managemant of ards
Ventilotry managemant of ards
 
ARDS Acute Respiratory Syndrome
ARDS Acute Respiratory SyndromeARDS Acute Respiratory Syndrome
ARDS Acute Respiratory Syndrome
 
Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0
 
Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0Acute Respiratory Distress-Syndrome_0
Acute Respiratory Distress-Syndrome_0
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
Medical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory DiseasesMedical Management and Perioperative Assessment of Respiratory Diseases
Medical Management and Perioperative Assessment of Respiratory Diseases
 
Acute lung injury
Acute lung injury Acute lung injury
Acute lung injury
 
Ards and ALI
Ards and ALIArds and ALI
Ards and ALI
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)
 
COPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptxCOPD Asthma and Approach to SOB HKJ.pptx
COPD Asthma and Approach to SOB HKJ.pptx
 
ARDS
ARDSARDS
ARDS
 
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
 
G M C F I N A L
G M C  F I N A LG M C  F I N A L
G M C F I N A L
 
Ards
ArdsArds
Ards
 
Acute Respiratory Distress Syndrome
Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
 
3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx3)ARDS -MANAGEMENT.pptx
3)ARDS -MANAGEMENT.pptx
 

Dernier

Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxsiddharthroy26587
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxAbdirahmanWaseem
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfNetHelix
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfHongBiThi1
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 

Dernier (20)

Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptxANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
ANATOMY OF CEREBELLUM With Clinical Anatomy.pptx
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
SMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptxSMA Implementation science seminar (Day 1).pptx
SMA Implementation science seminar (Day 1).pptx
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
Problems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdfProblems associated with the production of recombinant protein.pdf
Problems associated with the production of recombinant protein.pdf
 
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdfSGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
SGK BỆNH LÝ GOUT YHN hay lắm nha aaaa.pdf
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 

Acute Respiratory Distress Syndrome

  • 1. Acute Respiratory Distress Syndrome Dr. Rikin Hasnani Post Graduate Dept Of Pulmonary Medicine SVS Medical College Mahabubnagar Telangana State
  • 2. • Introduction • Pathophysiology • Clinical features • Management
  • 3. Introduction And Definition • In 1967, Ashbaugh et al. described a syndrome characterized by the acute onset of dyspnea, severe hypoxemia, diffuse lung infiltrates, and decreased respiratory system compliance in the absence of evidence for congestive heart failure (CHF). • In 1988, Murray and others introduced the Lung Injury Score (LIS), an assessment tool for ARDS. • The LIS incorporates four parameters that are graded on a scale of 0 to 4: (1) ratio of PaO2 to FIO2(PaO2/FIO2); (2) total respiratory compliance;(3) level of PEEP; and (4) extent of radiographic infiltrates. • In 1994 American European Consensus Conference (AECC) defined ARDS and ALI.
  • 4. Consensus Definition of ARDS • The AECC defines ARDS as the acute onset of illness with bilateral chest radiographic infiltrates consistent with pulmonary edema, poor systemic oxygenation, and absence of evidence for left atrial hypertension. • The syndrome was referred to as ALI when the ratio of PaO2 to FIO2 (PaO2/FIO2); was ≤300, and ARDS when the ratio was ≤200. • Limitations of this Definition.
  • 5. Berlin Definition - 2012 While the Berlin definition leaves the AECC definition of ARDS largely unchanged, the new definition addresses several specific ambiguities of the prior diagnostic criteria.
  • 6. Epidemiology • Incidence 75 cases per lakh population • Mortality 26 to 58% • more people die annually with ARDS than from AIDS, asthma, and breast cancer combined. • The most common causes of death among patients with ARDS arise from the underlying insult or subsequent nosocomial pneumonia and sepsis. • Only rarely do patients die from progressive hypoxia and respiratory failure.
  • 8. Factors influencing risk of ARDS • Not all patients with an underlying cause (e.g., sepsis) of ARDS develop the syndrome. • Clinical variables found to be associated with an increased risk of ARDS include chronic alcohol abuse, hypoproteinemia, advanced age, increased severity, and extent of injury or illness as measured by injury severity score (ISS) or APACHE score, hypertransfusion of blood products, and cigarette smoking. • Diabetes mellitus and prehospitalization antiplatelet therapy appear to decrease the risk of ARDS
  • 10. Predicting ARDS-Lung injury prediction score (LIPS) • It is generated by sum of six predisposing factors and 9 risk modifiers. • six predisposing conditions are shock, aspiration, sepsis, pneumonia, high-risk surgery, and high-risk trauma • nine risk modifiers alcohol abuse, obesity, hypoalbuminemia, chemotherapy, need for oxygen, tachypnea, hypoxia, academia, and diabetes mellitus • The negative predictive value for a score <4 was 97%, while the sensitivity and specificity for ARDS of a score >4 were 69% and 78%, respectively.
  • 11. Pathophysiology • The essential factors that govern fluid exchange in the lungs are expressed in the Starling equation for the microvascular barrier: Jv = LpS[(Pc – Pi) – σd(πc – πi)] The Starling equation predicts the development of two different kinds of pulmonary edema. Increased pressure pulmonary edema Increased permeability pulmonary edema
  • 14. Resolution of ARDS • Resolution of ARDS requires effective: • (1) reabsorption of alveolar edema, • (2) repair of the epithelial and endothelial barriers, and • (3) removal of inflammatory cells and exudates from the distal airspaces.
  • 15. Clinical Presentation • The development of ARDS usually follows a rapid course, occurring most often within 12 to 72 hours of the predisposing event. • Dyspnea usually associated with agitation, anxiety. • As lung compliance decreases there is increased WOB, small tidal volume and tachypnea. • The hallmark of ARDS is hypoxemia that is resistant to oxygen therapy because of the large right-to left shunt. • Initially, patients may be able to compensate by hyperventilating, thereby maintaining an acceptable PaO2 with an acute respiratory alkalosis. • Typically, patients deteriorate over several hours, requiring endotracheal intubation and mechanical ventilation.
  • 16. Differential Diagnosis of Acute Hypoxemic Respiratory Failure (AHRF)
  • 17. Approach to clinical Diagnosis • Chest x ray
  • 18. Lab investigations • Tropnin, BNP • LFT, RFT, hemogram • Bronchoscopy • Pancultures • Invasive hemodynamic monitoring is not recommended
  • 19. Approach to Treatment • Treatment of respiratory system abnormalities • Diagnose and treat the precipitating cause of ARDS, if possible • Maintain oxygenation, preferably using nontoxic FIO2 (<0.7), PEEP, or mechanical ventilation • Prevent ventilator-induced lung injury (VILI) by using a low tidal volume ventilatory strategy with a limit (≤30 cm H2O) on static end-inspiratory airway pressure (plateau pressure) • Keep pH in normal range without compromising goal to prevent VILI (but reverse a lifethreatening acidosis, even if it prevents meeting goal to prevent VILI) • Enhance patient–ventilator synchrony and patient comfort by use of sedation, amnesia, opioid analgesia, and pharmacologic paralysis, if necessary • Liberate or wean from mechanical ventilation when patient can breathe without assisted ventilation
  • 20. • Treatment of nonrespiratory system abnormalities • Support or treat other organ system dysfunction or failure • General critical care (preventive and homeostatic measures) • Adequate early nutritional support
  • 22. Maintaining Adequate oxygenation • High flow oxygen systems • Niv • Mechanical ventilation
  • 23. Lung protective MV • In contrast to the typical diffuse-appearing pattern noted on plain chest radiographs, the pattern of consolidation, atelectasis, and normal alveoli is actually heterogeneous. • The key physiologic implication of these observations is that a ventilator-delivered tidal volume is preferentially distributed to the open alveoli, which represent only a small fraction of the entire lung, BABY LUNG
  • 25. • The goals of lung-protective ventilation are to avoid injury due to overexpansion of alveoli during inspiration (so-called “volu-trauma”) and injury due to repetitive opening and closing of alveoli during inspiration and expiration (so-called “atelecta-trauma”). • The term “bio-trauma” encompasses the direct lung injury and the concomitant release of inflammatory cytokines that produce remote cell death or organ injury.
  • 26. Ventilator Strategy in ARDS 1. Ventilator Setup and Adjustment 2. Oxygenation Goal: PaO2 = 55–80 mm Hg or SpO2 = 88–95% 3. Plateau Pressure (Pplat) goal:≤30 cm H2O 4. pH Goal: 7.30–7.45
  • 27. Ventilator Setup and Adjustment • 1. Calculate ideal body weight (IBW)a (also known as predicted body weight [PBW]) • 2. Use Assist/Control mode and set initial TV to 8 mL/kg IBW (if baseline TV >8 mL/kg) • 3. Reduce TV by 1 mL/kg at intervals ≤2 h until TV = 6 mL/kg IBW • 4. Set initial rate to approximate baseline minute volume (but not >35 bpm) • 5. Adjust TV and RR to achieve pH and plateau pressure (Pplat) goals below. • 6. Set inspiratory flow rate above patient demand (usually >80 L/min); adjust flow rate to achieve goal of I:E ratio of 1:1.0–1.3
  • 28. Oxygenation Goal: • Goal is PaO2 = 55–80 mm Hg or SpO2 = 88–95% • 1. Use these incremental FIO2-PEEP combinations to achieve oxygenation goal
  • 29. Plateau Pressure (Pplat) goal:≤30 cm H2O • 1. Check Pplat (use 0.5-s inspiratory pause), SpO2, total RR, TV, and ABG (if available) at least every 4 h and after each change in PEEP or TV. • 2. If Pplat >30 cm H2O, decrease TV by 1 mL/kg steps (minimum 4 mL/kg IBW) • 3. If Pplat <25 cm H2O and TV <6 mL/kg, increase TV by 1 mL/kg until Pplat >25 cm H2O or TV = 6 mL/kg. • 4. If Pplat <20 cm H2O and breath stacking occurs, one may increase TV in 1 mL/kg increments (to a maximum of 8 mL/kg)
  • 30. pH Goal: 7.30–7.45 • Acidosis management: pH <7.30 • 1. If pH = 7.15–7.30, increase RR until pH >7.30 or PaCO2 <25 mm Hg (maximum RR = 35); if RR = 35 and PaCO2 <25 mm Hg, may give NaHCO3 • 2. If pH <7.15 and NaHCO3 considered or infused, TV may be increased in 1 mL/kg steps until pH>7.15 (Pplat goal may be exceeded)
  • 31. Rescue” or “Salvage” Interventions Used in Patients with ARDS and Severe Hypoxemia Resistant to Conventional Mechanical Ventilation and PEEP • Corticosteroids • Extracorporeal CO2 removal (ECCO2R) • Extracorporeal membrane oxygenation (ECMO) • High-frequency oscillatory ventilation (HFOV) • Inhaled nitric oxide (NO) or inhaled prostacyclin (epoprostenol/iloprost) • Pressure-controlled inverse ratio ventilation (PC-IRV) • Prone positioning • Recruitment maneuvers • Tracheal gas insufflation (TGI)
  • 33. • The study revealed no differences in 60- or 180-day mortality rates. • Although parameters of respiratory function, including PaO2/FIO2; plateau pressure; respiratory system compliance; and time to, and rate of, liberation from mechanical ventilation improved after corticosteroid administration; the corticosteroid treated group included more patients who returned to assisted ventilation. • Furthermore, no statistically significant differences between treated and untreated groups in ICU or hospital days by 180 days were observed. • In addition, more adverse events related to weakness occurred in the treated group than in those receiving placebo. • Finally, patients treated with corticosteroids after 14 days of persistent ARDS had a significantly increased mortality. • Hence, the results of this study do not support the routine use of steroids for late phase ARDS in general, and they argue against their use if ARDS has been present for 14 days or longer.
  • 34. Extracorporeal Life Support • Extracorporeal Life Support (ECLS) is a therapy that utilizes an external artificial membrane and a mechanical pump to provide gas exchange and systemic perfusion in patients with failure of lung and/or heart function. • The use of extracorporeal gas exchange, is based on the hypothesis that more patients will survive if the lung is allowed to recover from its injury by “resting” using extracorporeal gas exchange temporarily. • Extracorporeal membrane oxygenation (ECMO) and extracorporeal CO2 removal (ECCO2R) are types of ECLS.
  • 35. Death or severe disability, the study’s primary outcome, occurred in 53% of the conventional arm versus 37% of those referred to the ECMO center. Among those referred to the ECMO center, 76% received ECMO. While the study demonstrated a statistically significant finding, the study design makes it impossible to distinguish the effects of the ECMO therapy from those of a specialized referral center.
  • 36. High-frequency oscillatory ventilation (HFOV) • High-frequency oscillatory ventilation (HFOV) is a mode of ventilation in which patients are supported with rapid pressure oscillations that generate very small tidal volumes. • Theoretically, HFOV may be regarded as the ultimate low-tidal volume ventilator. • There is no significant mortality benefit over usual icu care. So not recommended
  • 37. Inhaled NO • Given via inhalation, NO selectively vasodilates pulmonary capillaries and arterioles that serve ventilated alveoli, diverting blood flow to these alveoli and away from areas of shunt. • Lowering of the pulmonary vascular resistance, accompanied by lowering of the pulmonary artery pressure, appears maximal at very low concentrations (0.1 ppm) in patients with ARDS. • Inhaled NO has been studied in several controlled clinical trials in patients with ARDS. • While demonstrating improvements in oxygenation in some patients, inhaled NO did not improve survival in any of the trials.
  • 38. Tracheal Gas Insufflation • Tracheal gas insufflation (TGI) consists of delivering fresh gas through a modified endotracheal tube at a point just above the carina. • The additional gas flow (i.e., flow provided in addition to the standard tidal volumes delivered by the ventilator) tends to remove CO2-rich gas from the trachea and smaller airways. • Disadvantage with TGI - tracheal erosion, oxygen toxicity related to an increased FIO2, and hemodynamic compromise or barotrauma due to TGI-induced auto-PEEP and a larger tidal volume than the ventilator is set to deliver • its routine use is not recommended.
  • 39. PCV -IRV • PCV can limit maximal peak airway pressure as well as end-inspiratory pressure and, hence, is favored by some clinicians. • However, the end-inspiratory pressure in PCV can be underestimated • TV delivered at set pressure is compliance dependent. Tv will increase as ARDS improves. • Inverse ratio ventilation (IRV) with PCV is based upon an inspiratory time (I) greater than expiratory time (E), that is, I:E >1 . • Lengthening the inspiratory time increases mean airway pressure because more of the respiratory cycle is spent in inspiration, which may translate into improvements in oxygenation.
  • 40. Prone Ventilation • About two-thirds of patients with ARDS improve their oxygenation after being placed in a prone position. • Mechanisms that improves oxygenation • (1) increased functional residual capacity; • (2) change in regional diaphragmatic motion; • (3) perfusion redistribution; and • (4) improved clearance of secretions.
  • 42. Problems with prone ventilation • Patients managed in the prone position need special attention to prevent pressure necrosis of the nose, face, and ears. • Extra care is also needed to ensure security and patency of the endotracheal tube. • Pressure on the eye may result in retinal ischemia, especially in hypotensive patients. • There are incidence of cardiac arrhythmias or hemodynamic instability when turned prone.
  • 44. Recruitment maneuver • Lung recruitment maneuvers are defined as the application of CPAP aimed at “recruiting” or opening totally or partially collapsed alveoli. • The alveoli are then kept inflated during expiration using an appropriately high level of PEEP. • Methods of recruitment 1. 40cmH20 for 40-60 seconds 2. 3 consecutive sighs/min with a plateau pressure of 45cmH2O 3. 2 minutes of peak pressure of 50cmH2O and PEEP above upper inflection point (obese/trauma patients may require >60-70cmH2O) 4. long slow increase in inspiratory pressure up to 40 cmH2O (RAMP) 5. stepped increase in pressure (e.g. Staircase Recruitment Manoeuvre)
  • 46. • FACTT investigators developed a detailed fluid management protocol that, except for patients in shock (mean arterial pressure [MAP] less than 60 mm Hg or on vasopressors for hypotension), used four basic input variables (assessed every 1–4 hours) to determine the fluid management instructions: • (1) MAP; • (2) urine output; • (3) effectiveness of circulation; and • (4) intravascular pressure (central venous pressure [CVP] or PAOP
  • 48. Other therapies • Neuromuscular blocking agent • Beta agonists • Macrolide • Statins